Effect of Bevacizumab Plus Temozolomide-Radiotherapy for Newly Diagnosed Glioblastoma with Different MGMT Methylation Status: A Meta-Analysis of Clinical Trials

BACKGROUND: MGMT methylation status can influence the therapeutic effect and prognosis of glioblastoma (GBM). There are conflicting results from studies evaluating the efficacy of bevacizumab (BV) when it is combined with temozolomide (TMZ) and radiotherapy (RT) in patients diagnosed with GBM with d...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Chigang, Ren, Junquan, Zhang, Rui, Xin, Tao, Li, Zhongmin, Zhang, Zhiti, Xu, Xinghua, Pang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2016
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045921/
https://www.ncbi.nlm.nih.gov/pubmed/27684457
http://dx.doi.org/10.12659/MSM.899224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045921/
https://www.ncbi.nlm.nih.gov/pubmed/27684457
http://dx.doi.org/10.12659/MSM.899224

Ejemplares similares